The use of rosiglitazone or bedtime insulin in the treatment of conventional oral anti-diabetic drug failure: a one-year randomized clinical trial

Completed

• Conditions: Type 2 diabetic patients with conventional OAD failure; Nutritional, Metabolic, Endocrine; Diabetes

• Registration Number: ISRCTN33022160
• Lead Sponsor: AH Nethersole Hospital, Department Research Fund (Hong Kong)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2006-04-25
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 110

Inclusion Criteria

Chinese type 2 diabetic patients with conventional OAD failure

Exclusion Criteria

Type 1 diabetes

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Glycaemic improvement

Secondary Outcome Measures

Name	Time	Method
1. Lipid and blood pressure (BP) changes<br>2. Tolerability